Ketamine
Ketamine is a pharmaceutical drug with 679 clinical trials. Currently 73 active trials ongoing. Historical success rate of 84.8%.
Success Metrics
Based on 379 completed trials
Phase Distribution
Phase Distribution
120
Early Stage
131
Mid Stage
248
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
77.5%
379 of 489 finished
22.5%
110 ended early
73
trials recruiting
679
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Sedation Methods in Percutaneous Transhepatic Biliary Drainage: Procedure Quality and Recovery
Multi-center RCT of IV Ketamine Efficacy and Safety in Chronic Daily Headaches
Imaging SV2A in Mood Disorders
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
Ketamine-Assisted Recovery for Methamphetamine Use Disorder & HIV
Clinical Trials (679)
Sedation Methods in Percutaneous Transhepatic Biliary Drainage: Procedure Quality and Recovery
Multi-center RCT of IV Ketamine Efficacy and Safety in Chronic Daily Headaches
Imaging SV2A in Mood Disorders
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
Ketamine-Assisted Recovery for Methamphetamine Use Disorder & HIV
Effect of Ketamine and Etomidate During RSI on Long Term Outcomes
Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy
Ketamine for Multiple Sclerosis Fatigue
Glutamatergic Adaptation to Stress as a Mechanism for Anhedonia and Treatment Response With Ketamine
Predictors of Intravenous Ketamine Response in TRD
Ketamine and Propofol NeuroImaging
ESKetamine Low-dose vs Ketamine Low-dose for Severe Acute Pain in Emergency Units, Comparison of PsychodyslEptic Effects
Ketamine in Central Sensitization
Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic Cancer
Effects of TAK-063 on Preventing Ketamine-Induced Brain Activity Changes as Well as Psychotic-Like Symptoms in Healthy Male Adults
Effects of Dexmedetomidine Versus Ketamine on Inflammatory Response and Hemodynamic in Patients
Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response
The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects
Prospective Study of Induction Medications Used in the Trauma RSI
Ketamine Alcohol (in Treatment-Resistant Depression)
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 679